Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Free Cash Flow (2022 - 2025)

GE HealthCare Technologies' Free Cash Flow history spans 4 years, with the latest figure at $997.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 6.74% year-over-year to $997.0 million, compared with a TTM value of $1.8 billion through Dec 2025, up 0.61%, and an annual FY2025 reading of $1.8 billion, up 0.61% over the prior year.
  • Free Cash Flow for Q4 2025 was $997.0 million at GE HealthCare Technologies, up from $572.0 million in the prior quarter.
  • The five-year high for Free Cash Flow was $1.1 billion in Q4 2024, with the low at -$142.0 million in Q2 2024.
  • Average Free Cash Flow over 4 years is $463.8 million, with a median of $461.5 million recorded in 2023.
  • Year-over-year, Free Cash Flow crashed 94.52% in 2024 and then skyrocketed 209.86% in 2025.
  • Tracing GEHC's Free Cash Flow over 4 years: stood at $986.0 million in 2022, then increased by 0.41% to $990.0 million in 2023, then rose by 7.98% to $1.1 billion in 2024, then dropped by 6.74% to $997.0 million in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Free Cash Flow are $997.0 million (Q4 2025), $572.0 million (Q3 2025), and $156.0 million (Q2 2025).